Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Validating electronic source data in clinical trials.

Ronald G Marks1

  • 1Department of Biostatistics, College of Medicine, University of Florida, P.O. Box 100212, Gainesville, FL 32610-0212, USA. ronmarks@ufl.edu

Controlled Clinical Trials
|October 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

JAMA·2003
Same journal

On the generation and ownership of alpha in medical studies.

Controlled clinical trials·2004
Same journal

An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.

Controlled clinical trials·2004
Same journal

Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture.

Controlled clinical trials·2004
Same journal

Statistical comparison of random allocation methods in cancer clinical trials.

Controlled clinical trials·2004
Same journal

Analyzing bronchodilation with emphasis on disease type, age and sex.

Controlled clinical trials·2004
Same journal

Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.

Controlled clinical trials·2004
See all related articles

The clinical trials industry is transitioning from paper to electronic source documents for data capture. This paper explores the history, reasons for slow adoption, and methods for validating electronic source data in clinical research.

Area of Science:

  • Clinical research operations
  • Health informatics
  • Regulatory science

Background:

  • Clinical trials traditionally rely on paper-based source documents for data collection.
  • Despite advancements in computing and internet-based solutions, the clinical trials industry has lagged in adopting electronic technologies.
  • This reliance on paper hinders efficiency and innovation in clinical research.

Purpose of the Study:

  • To summarize the historical evolution of clinical data capture methods, from paper to electronic systems.
  • To identify key reasons contributing to the slow adoption of electronic source data in clinical trials.
  • To present and illustrate methods for validating electronic source data.

Main Methods:

  • Historical review of clinical data capture practices.

Related Experiment Videos

  • Analysis of factors influencing technology adoption in clinical trials.
  • Illustration of two distinct methods for electronic source data validation.

    • Main Results:

    • The clinical trials industry has a long history of paper-based data collection.
    • Three primary reasons are identified for the slow transition to electronic source data.
    • Two methods for ensuring the validity of electronic source data are demonstrated.

    Conclusions:

    • Transitioning to electronic source data offers significant potential for enhancing clinical trial conduct.
    • Addressing concerns regarding data validation is crucial for successful electronic source data implementation.
    • Further exploration and adoption of validated electronic systems are recommended for the clinical trials industry.